OBJECTIVES: To determine support of in-pharmacy human immunodeficiency virus (HIV) testing among pharmacy staff and the individual-level characteristics associated with in-pharmacy HIV testing support. DESIGN: Descriptive, nonexperimental, cross-sectional study. SETTING:New York City (NYC) from January 2008 to March 2009. PARTICIPANTS: 480 pharmacy staff, including pharmacists, owners/managers, and technicians/clerks. INTERVENTION: 131 pharmacies registered in the Expanded Syringe Access Program (ESAP) completed a survey. MAIN OUTCOME MEASURE: Support of in-pharmacy HIV testing. RESULTS: Support of in-pharmacy HIV testing is high among pharmacy staff (79.4%). Pharmacy staff who supported in-pharmacy vaccinations were significantly more likely to support in-pharmacy HIV testing. Pharmacy staff who thought that selling syringes to injection drug users (IDUs) caused the community to be littered with dirty syringes were significantly less likely to support in-pharmacy HIV testing. CONCLUSION: Support for in-pharmacy HIV testing was high among our sample of ESAP pharmacy staff actively involved in nonprescription syringe sales. These findings suggest that active ESAP pharmacy staff may be amenable to providing HIV counseling and testing to IDUs and warrants further investigation.
RCT Entities:
OBJECTIVES: To determine support of in-pharmacy human immunodeficiency virus (HIV) testing among pharmacy staff and the individual-level characteristics associated with in-pharmacy HIV testing support. DESIGN: Descriptive, nonexperimental, cross-sectional study. SETTING: New York City (NYC) from January 2008 to March 2009. PARTICIPANTS: 480 pharmacy staff, including pharmacists, owners/managers, and technicians/clerks. INTERVENTION: 131 pharmacies registered in the Expanded Syringe Access Program (ESAP) completed a survey. MAIN OUTCOME MEASURE: Support of in-pharmacy HIV testing. RESULTS: Support of in-pharmacy HIV testing is high among pharmacy staff (79.4%). Pharmacy staff who supported in-pharmacy vaccinations were significantly more likely to support in-pharmacy HIV testing. Pharmacy staff who thought that selling syringes to injection drug users (IDUs) caused the community to be littered with dirty syringes were significantly less likely to support in-pharmacy HIV testing. CONCLUSION: Support for in-pharmacy HIV testing was high among our sample of ESAP pharmacy staff actively involved in nonprescription syringe sales. These findings suggest that active ESAP pharmacy staff may be amenable to providing HIV counseling and testing to IDUs and warrants further investigation.
Authors: A E Rudolph; K Standish; S Amesty; N D Crawford; R J Stern; W E Badillo; A Boyer; D Brown; N Ranger; J M Garcia Orduna; L Lasenburg; Sarah Lippek; Crystal M Fuller Journal: AIDS Educ Prev Date: 2010-06
Authors: Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark Journal: MMWR Recomm Rep Date: 2006-09-22
Authors: Guthrie S Birkhead; Susan J Klein; Alma R Candelas; Daniel A O'Connell; Jeffrey R Rothman; Ira S Feldman; Dennis S Tsui; Richard A Cotroneo; Colleen A Flanigan Journal: Int J Drug Policy Date: 2007-02-20
Authors: Don C Des Jarlais; Kamyar Arasteh; Holly Hagan; Courtney McKnight; David C Perlman; Samuel R Friedman Journal: Am J Public Health Date: 2009-10 Impact factor: 9.308
Authors: L Platt; P Vickerman; M Collumbien; S Hasan; N Lalji; S Mayhew; R Muzaffar; A Andreasen; S Hawkes Journal: Sex Transm Infect Date: 2009-04 Impact factor: 3.519
Authors: Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Holly Hagan; David C Perlman; Lucia V Torian; Sara Beatice; Salaam Semaan; Samuel R Friedman Journal: Drug Alcohol Depend Date: 2010-02-16 Impact factor: 4.492
Authors: Yvette Calderon; Ethan Cowan; John Y Rhee; Christopher Brusalis; Jason Leider Journal: AIDS Patient Care STDS Date: 2013-07-24 Impact factor: 5.078
Authors: Crystal M Fuller; Alezandria K Turner; Diana Hernández; Alexis V Rivera; Silvia Amesty; Michael D Lewis; Stuart Feldman Journal: J Am Pharm Assoc (2003) Date: 2013 Nov-Dec
Authors: Beth E Meyerson; Carrie A Lawrence; Summer Dawn Cope; Steven Levin; Christopher Thomas; Lori Ann Eldridge; Haley B Coles; Nina Vadiei; Amy Kennedy Journal: Harm Reduct J Date: 2019-09-18
Authors: Sonia Fernández-Balbuena; María José Belza; Daniel Zulaica; Jose Luis Martinez; Henar Marcos; Benet Rifá; Arantxa Arrillaga; Luis de la Fuente; Juan Hoyos Journal: PLoS One Date: 2015-08-06 Impact factor: 3.240
Authors: B E Meyerson; J D Agley; A Davis; W Jayawardene; A Hoss; D J Shannon; P T Ryder; K Ritchie; R Gassman Journal: Drug Alcohol Depend Date: 2018-04-26 Impact factor: 4.492